FIGO / IGCS statement on the efficacy of topical treatments for high‐risk human papillomavirus in preventing CIN 3+ lesions
Year: 2026
Type: article
DOI: 10.1002/ijgo.71285
Authors: René Pareja, Fernando Heredia, Emmanuel Sánchez‐Díaz, Mauricio A. Cuello, Silvia de Sanjosé, José Jerónimo, Suzanne M. Garland, Marta del Pino, Angélica Fletcher, Aureli Torné, Gabriel Levin, Lisa Flowers, Munachiso Iheme Ndukwe, Lina María Trujillo, Sarikapan Wilailak, Neerja Bhatla, Christina Fotopoulou, Barbara Schmalfeldt, Gloria Inés Sánchez, Maria Kyrgiou, Patrick Petignat, Nadeem Abu‐Rustum
Institutions: Instituto Nacional de Cancerología, University of Concepción, Pontificia Universidad Católica de Chile, Barcelona Institute for Global Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics, Royal Women's Hospital, The University of Melbourne, Murdoch Children's Research Institute, Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona, McGill University Health Centre, McGill University, Emory University, Charles University, Mahidol University, Ramathibodi Hospital, All India Institute of Medical Sciences, Imperial College London, University Medical Center Hamburg-Eppendorf, Universidad de Antioquia, Imperial College Healthcare NHS Trust, University Hospital of Geneva, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7204867994